These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 29895157)

  • 1. Construction, identification, and immunogenic assessments of an HSV-1 mutant vaccine with a UL18 deletion.
    Wang L; Aoli Wang Q; Jin F; Fang S; Luo F; Wu Y; Li F; Liu J; Wang Y; Jin J; Liao X; Ren Z; Wang Y
    Acta Virol; 2018; 62(2):164-171. PubMed ID: 29895157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect.
    Xu X; Feng X; Wang L; Yi T; Zheng L; Jiang G; Fan S; Liao Y; Feng M; Zhang Y; Li D; Li Q
    PLoS Pathog; 2020 Aug; 16(8):e1008703. PubMed ID: 32776994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.
    Royer DJ; Carr MM; Chucair-Elliott AJ; Halford WP; Carr DJJ
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28122977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing Viral Inhibition of Host Cellular Apoptosis Strengthens the Immunogenicity and Protective Efficacy of an Attenuated HSV-1 Strain.
    Xu X; He Y; Fan S; Feng M; Jiang G; Wang L; Zhang Y; Liao Y; Li Q
    Virol Sin; 2019 Dec; 34(6):673-687. PubMed ID: 31506828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach.
    Jin F; Li S; Zheng K; Zhuo C; Ma K; Chen M; Wang Q; Zhang P; Fan J; Ren Z; Wang Y
    PLoS One; 2014; 9(5):e96623. PubMed ID: 24794394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
    Awasthi S; Lubinski JM; Eisenberg RJ; Cohen GH; Friedman HM
    Vaccine; 2008 Feb; 26(9):1195-203. PubMed ID: 18243431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity.
    Lauterbach H; Ried C; Epstein AL; Marconi P; Brocker T
    J Gen Virol; 2005 Sep; 86(Pt 9):2401-2410. PubMed ID: 16099897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
    Royer DJ; Gurung HR; Jinkins JK; Geltz JJ; Wu JL; Halford WP; Carr DJJ
    J Virol; 2016 Jun; 90(11):5514-5529. PubMed ID: 27030264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies.
    Stanfield BA; Pahar B; Chouljenko VN; Veazey R; Kousoulas KG
    Vaccine; 2017 Jan; 35(4):536-543. PubMed ID: 28017425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
    Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
    Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice.
    El-Ghorr AA; Williams RM; Heap C; Norval M
    FEMS Immunol Med Microbiol; 2000 Dec; 29(4):255-61. PubMed ID: 11118905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice.
    Thebeau LG; Vagvala SP; Wong YM; Morrison LA
    J Virol; 2007 Nov; 81(22):12200-9. PubMed ID: 17804511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge.
    Jamali A; Roostaee MH; Soleimanjahi H; Ghaderi Pakdel F; Bamdad T
    Comp Immunol Microbiol Infect Dis; 2007 Mar; 30(2):71-80. PubMed ID: 17126902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
    Hoshino Y; Dalai SK; Wang K; Pesnicak L; Lau TY; Knipe DM; Cohen JI; Straus SE
    J Virol; 2005 Jan; 79(1):410-8. PubMed ID: 15596834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential prophylactic and therapeutic vaccines for HSV infections.
    Ramachandran S; Kinchington PR
    Curr Pharm Des; 2007; 13(19):1965-73. PubMed ID: 17627530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.